What type of study is this?

This is a Human Clinical Trial study.

What question did this study set out to answer?

This review summarizes advances in glucokinase activators for treating type 2 diabetes.

April 30, 2026Die PharmazieOpen Access

Recent clinical advances of glucokinase activators in the treatment of diabetes mellitus type 2

View Full Paper

Ask AI

Bookmark

Authors

WLWenhua LiSouth China Agricultural University XZXiaoqing ZhangHebei Medical University YSYan SunFujian Medical University

Discussion

Member takes

Implication

This review shows glucokinase activators improve blood glucose control in type 2 diabetes, indicating a potential to reverse β-cell functional decline.

Key Points

This review summarizes advances in glucokinase activators for treating type 2 diabetes.
Overview of glucokinase activators development and mechanisms
Review of animal models and clinical trial phases
Discussion of clinical outcomes related to glucose control
Dorzagliatin reached primary endpoints in phase III trials
Glucokinase activators can improve blood glucose control
Potential to repair islet β-cell function and delay damage

Cite This Study

Li et al. (2020) studied this question.

synapsesocial.com/papers/69f2a42a8c0f03fd67763398 https://doi.org/10.31083/ph.2020.0409

View Full Paper

Ask AI

Bookmark

Implication

This review shows glucokinase activators improve blood glucose control in type 2 diabetes, indicating a potential to reverse β-cell functional decline.

Recent clinical advances of glucokinase activators in the treatment of diabetes mellitus type 2

Discussion

Member takes

Implication

Key Points

Cite This Study

Recent clinical advances of glucokinase activators in the treatment of diabetes mellitus type 2

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider